Haemophilia A/sialorrhoea: Comparator therapies not implemented, added benefit not proven

(Institute for Quality and Efficiency in Health Care) In two early benefit assessments, IQWiG was unable to derive an added benefit from the data presented because current standards of care were not implemented in the studies.